Came across this article today:
Clearly written from a certain angle about a spin-out company that is talking up its potential to secure more funding. Am always sceptical of any supposed “cure”, but thought it was interesting. Their website suggests that Gavin Giovannoni is lined up to lead clinical trials from 2020. Couldn’t find anything on MS Trust or MS Society websites about it. Barts blog has something from 2015: http://multiple-sclerosis-research.blogspot.com/search?q=LIF&max-results=20&by-date=true
Maybe it is old news which I missed before and it is being promoted locally to help with the next round of fundraising, but would be interested to know if anyone else has heard about it. Thanks.
You must be logged in to reply to this topic.